RPG Life SciencesNSE:RPGLIFE +1.75%92 Gross Margin % is 65.75% as of Mar. 2026, which is 1% above its 10-year median of 65.32. GuruFocus rates NSE:RPGLIFE with a GF Score™ of 92/100 and a GF Value™ of ₹2,364.94 (Fairly Valued). The stock has 3 warning signs investors should review. Among 937 Drug Manufacturers companies, RPG Life Sciences ranks better than 74.92% on this metric.
The historical rank and industry rank for RPG Life Sciences's Gross Margin % or its related term are showing as below:
NSE:RPGLIFE'
s Gross Margin % Range Over the Past 10 Years
Min: 63.52 Med: 65.32 Max: 67.25
Current: 64.37
During the past 13 years, the highestGross Margin % of RPG Life Sciences was 67.25%. The lowest was 63.52%. And the median was 65.32%.
NSE:RPGLIFE's Gross Margin % is ranked better than 74.92% of 937
companies
in the Drug Manufacturers industry
Industry Median: 48.46
vs NSE:RPGLIFE: 64.37
RPG Life Sciences had a gross margin of 65.75% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for RPG Life Sciences was 0.30% per year.
RPG Life Sciences (NSE:RPGLIFE) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
RPG Life Sciences had a gross margin of 65.75% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
RPG Life Sciences Gross Margin % Related Terms
RPG Life Sciences Gross Margin % Historical Data
* Premium members only.
The historical data trend for RPG Life Sciences's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:RPGLIFE vs ZTS, UTHR: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RPG Life Sciences Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Gross Margin % distribution charts can be found below:
* The bar in red indicates where RPG Life Sciences's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
RPG Life Sciences (NSE:RPGLIFE) has a Gross Margin % of 65.75% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on RPG Life Sciences and its competitors. This is near median its historical median of 65.32. Over the past decade, RPG Life Sciences' Gross Margin % has ranged from 63.52 to 67.25. According to the industry distribution chart, RPG Life Sciences ranks #235 out of 937 companies in the Drug Manufacturers industry, placing it in the top 25.1%.
Is RPG Life Sciences' Gross Margin % too high?
RPG Life Sciences' current Gross Margin % of 65.75% is near median its 10-year median of 65.32. Over the past 10 years, this metric has ranged from a low of 63.52 to a high of 67.25. The Drug Manufacturers industry median Gross Margin % is 48.46. RPG Life Sciences' value of 65.75% is 35.7% above this industry median. Based on the distribution chart, RPG Life Sciences ranks #235 out of 937 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, RPG Life Sciences has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, RPG Life Sciences ranks #235 out of 937 companies for Gross Margin %. This puts RPG Life Sciences in the upper half of its industry. The industry median Gross Margin % is 48.46. RPG Life Sciences' value of 65.75% is 35.7% above this benchmark. Historically, RPG Life Sciences' own Gross Margin % has ranged from 63.52 to 67.25 over the past decade. While the company's 10-year median is 65.32 vs. the industry median of 48.46, RPG Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.46, based on 937 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RPG Life Sciences's current Gross Margin % of 65.75% is 35.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on RPG Life Sciences and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RPG Life Sciences's current Gross Margin % is 65.75%, which is near median its own 10-year median of 65.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,364.94, compared to a current price of ₹2,393.70 — trading 1.2% above its estimated fair value. The current Gross Margin % is 65.75%, which is near median its 10-year median of 65.32 and 35.7% above the Drug Manufacturers industry median of 48.46. RPG Life Sciences' overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Gross Margin % is 65.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, RPG Life Sciences stock appears to be overvalued.
The current stock price of ₹2,393.70 is trading 1.2% above its estimated GF Value™ of ₹2,364.94.
GuruFocus considers RPG Life Sciences to be Fairly Valued.
Key valuation signals for NSE:RPGLIFE:
Gross Margin %: 65.75% (near median its 10-year median of 65.32)
GF Value™: ₹2,364.94 vs. price of ₹2,393.70 (1.2% above fair value)
Industry Position: 35.7% above the Drug Manufacturers median (#235 of 937)
No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
92GF Score
Get the complete analysis for NSE:RPGLIFE
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RPGLIFE has been successfully added to your 
